InvestorsHub Logo
Followers 155
Posts 18494
Boards Moderated 0
Alias Born 02/29/2008

Re: None

Tuesday, 08/08/2017 3:31:34 PM

Tuesday, August 08, 2017 3:31:34 PM

Post# of 8425
Synthetic Biologics, Inc. SYN is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. Synthetic Biologics has a Zacks Rank #2 (Buy) and its average EPS surprise over the last four quarters is 51.6%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News